HOME >> BIOLOGY >> NEWS
Assumption of function not always correct

HOUSTON (May 1, 2007) - A protein called RecQ takes on a totally opposite function in the bacteria Escherichia coli to the one it fulfills in yeast and in humans, indicating that people seeking to understand the role of different forms in human cells and disease need to consider both possibilities, said researchers from Baylor College of Medicine in a report in the current issue of Molecular Cell.

Humans have five forms of this particular protein, and three are associated with syndromes that predispose people to cancer, said Dr. Susan Rosenberg, professor of molecular and human genetics at Baylor College of Medicine. Two of the forms are not associated with cancer syndromes.

Other organisms have forms of this protein in varying numbers, said Rosenberg. For example, E. coli has only one. All forms appear to be very similar, no matter what the organism. When proteins are found in a variety of organisms, they are called conserved.

"It was thought that because these were so well conserved, they should do more or less the same thing," said Rosenberg. However, research in her laboratory showed this was not the case.

In yeast and one of the human forms of a protein called RecQ actually works to help unzip DNA strands when chromosomes repair DNA damage using a process called genetic recombination. In this kind of repair, one chromosome aggregates with a partner chromosomeusually its twin chromosome following DNA replicationand then disaggregates following repair. If the repair aggregates are not unzipped, the chromosomes can't separate for reproduction. The yeast and human Werner syndrome enzymes helps prevent the buildup of unwanted intermediates of aggregated chromosomes that can actually kill the cells if not unzipped.

When that protein is lacking, the intermediates buildup and the cells die. However, while many people think all such proteins work similarly in repair, recent work by Rosenberg and others in her la
'"/>

Contact: Graciela Gutierrez
ggutierr@bcm.edu
713-798-4710
Baylor College of Medicine
1-May-2007


Page: 1 2

Related biology news :

1. Assumptions of effects of rising carbon dioxide probed
2. UCLA scientists produce functioning neurons from human embryonic stem cells
3. Cardiac patches stimulate regeneration, improve function after heart attack
4. Accident-prone? Scientists link brain function to knee injuries
5. Researchers use new approach to predict protein function
6. Engineered blood vessels function like native tissue
7. Translating form into function
8. Research finds that circadian rhythms dominate all life functions
9. Mucosal-surface immune function discoveries could boost vaccine research
10. University of Washington researchers play leading role in major study of human genome function
11. What causes Alzheimers? Researchers tie beta-amyloids to brain dysfunction

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... 02, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... approved clinical trial for stem cell treatment of knee osteoarthritis . The successful enrollment ... a subsidiary of VetStem Biopharma. , PSC CEO, Michael Dale, stated, “We are proud ...
(Date:9/30/2019)... ... September 30, 2019 , ... RoosterBio ... stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent approval ... formats (patent number AU 2015259373). This new patent adds intellectual property (IP) ...
(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures (DSV), a ... world’s largest independent funder of cancer research. , Deep Science Ventures was founded to ... view of the opportunity from the start, both at the industry and biological level. ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... ... new life sciences leadership firm that is enabling clinical program outsourcing success by ... Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients ...
(Date:10/3/2019)... ... , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New ... M.D., Ph.D., discussed important design factors that currently limit the success of early stage ... of clinical trials, in his talk Dr. Sherley focused on the highly ...
(Date:9/24/2019)... and WALTHAM, Mass. (PRWEB) , ... ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of ...
(Date:9/22/2019)... BEAVERTON, Ore. (PRWEB) , ... September 20, 2019 ... ... the commercial launch of Brain-Derived Neurotrophic Factor (BDNF) testing in serum . ... peripheral nervous systems. BDNF stimulates the growth and differentiation of new neurons in ...
Breaking Biology Technology:
Cached News: